RA
CVS icon

Royce & Associates’s CVS Health CVS Stock Holding History

Royce & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,000
Closed -$1.71M – 813
2024
Q4 		$1.71M Sell
38,000
-49,000
-56% -$2.75M 0.02% 649
2024
Q3 		$5.47M Buy
87,000
+2,000
+2% +$117K 0.05% 458
2024
Q2 		$5.02M Buy
85,000
+16,500
+24% +$1.03M 0.05% 484
2024
Q1 		$5.46M Hold
68,500
– – 0.05% 478
2023
Q4 		$5.41M Hold
68,500
– – 0.05% 479
2023
Q3 		$4.78M Buy
68,500
+11,000
+19% +$779K 0.05% 482
2023
Q2 		$3.97M Buy
57,500
+14,000
+32% +$996K 0.04% 553
2023
Q1 		$3.23M Buy
+43,500
New +$3.65M 0.03% 588

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royce & Associates's CVS Position: Q1 2025 in Review

Royce & Associates sold out of CVS Health (CVS) in Q1 2025, closing a stake of 38,000 shares — an estimated $1.71M sold.

Royce & Associates first reported a position in CVS in Q1 2023 and held it in 8 quarters. The position peaked at $5.47M in Q3 2024. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Royce & Associates reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Royce & Associates sold 38,000 CVS Health shares in Q1 2025, an estimated $1.71M.
  • Royce & Associates first reported a position in CVS Health in Q1 2023 and held it in 8 quarters.
  • Royce & Associates's CVS Health position peaked at $5.47M in Q3 2024.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Royce & Associates's 13F filing for Q1 2025, filed 6 May 2025.